Nanosphere to Announce Third Quarter Financial Results & Host Investor Call on Monday, November 9
02 nov. 2015 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will report...
Impact of Verigene Blood Culture Tests Highlighted by Five Studies Presented at ICAAC 2015
22 sept. 2015 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced that new clinical data...
Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test
08 sept. 2015 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 8, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing the practice of medicine through targeted molecular diagnostics, today announced it has received...
Nanosphere Announces Record Q2 2015 Results
10 août 2015 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results...
Nanosphere Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders
31 juil. 2015 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 31, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that it has amended certain...
New Studies Highlight Antibiotic Resistance Detection With Nanosphere's Verigene Blood Culture Tests
22 juin 2015 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that seven studies evaluating...
Nanosphere Announces $4.4 Million at the Market Registered Direct Offering
08 juin 2015 16h14 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 8, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced today that it has entered into a...
Eighteen New Verigene Clinical and Economic Studies Presented at CVS, ECCMID and MAD-ID 2015
27 mai 2015 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 27, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that 18 studies performed by...
Nanosphere Announces Closing of New and Expanded Debt Facility and $4.4 Million at the Market Registered Direct Offering
15 mai 2015 09h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 15, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today the closing of its previously...
Nanosphere Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million at the Market Registered Direct Offering and Next Generation Verigene System Progress
11 mai 2015 17h30 HE
|
Nanosphere, Inc.
Corporate Highlights:
Record Q1 revenues of $4.6 million confirming full year guidance
New and Expanded Debt Facility
Pricing of $4.4 million at the market registered...